Drug Trial Radar · NCT06096337
Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation
Last checked: Nov 20, 2026Latest source record: Aug 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
484
Actual
Start
Dec 28, 2023
Primary completion
Feb 4, 2026
Study completion Feb 4, 2028
Sponsor
- Lead sponsor
- Boston Scientific CorporationIndustry
- Sponsor type
- Industry
- First posted
- Oct 23, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to establish the safety and effectiveness of pulsed field ablation as a first-line ablation treatment for subjects with persistent atrial fibrillation as compared to subjects who received an initial treatment with anti-arrhythmic drugs.
Conditions
- Persistent Atrial Fibrillation
Interventions
FARAPULSE™ Pulsed Field Ablation (PFA) SystemDevice
Subjects will undergo a pulsed field ablation procedure using the FARAPULSE™ Pulsed Field Ablation (PFA) System for the isolation of pulmonary veins and posterior wall.
Anti-Arrhythmic Drug (AAD): Flecainide, Sotalol, Propafenone, Dofetilide, and DronedaroneDrug
Anti-Arrhythmic Drugs (AADs) including, Flecainide, Sotalol, Propafenone, Dofetilide, and Dronedarone will be prescribed and monitored in accordance with local clinical practice and already established guideline-directed therapy for patients with persistent atrial fibrillation (AF).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rate of randomized PFA or PFA Assigned subjects with PFA System inserted into the body, during the index or repeat PFA procedure during blanking period, with device or procedure-related Composite Adverse Events that is serious.Time frame: 12-Months
- Rate of intent to treat subjects with treatment success from the pulse field ablation treatment and Anti-Arrhythmic Drug treatment.Time frame: 12-Months
Locations
61 sites in 13 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Banner University Medical Center Phoenix
Phoenix, Arizona
Phoenix Cardiovascular Research Group
Phoenix, Arizona
Arrhythmia Research Group
Jonesboro, Arkansas
Scripps Memorial Hosptial
La Jolla, California
Stanford University Medical Center
Palo Alto, California
Cardiology Associates Medical Group, Inc
Ventura, California
HCA Florida Mercy Hospital
Miami, Florida
Sarasota Memorial Hospital
Sarasota, Florida
Tallahassee Memorial Hospital
Tallahassee, Florida
St. Joseph's Hospital
Tampa, Florida
Emory University Hospital
Atlanta, Georgia
Memorial Health University Medical Center
Savannah, Georgia
St. John's Hospital
Springfield, Illinois
Community Heart and Vascular Hospital
Indianapolis, Indiana
Mercy Hospital Medical Center-Hospital
West Des Moines, Iowa
Baptist Health Lexington
Lexington, Kentucky
Johns Hopkins Hospital
Baltimore, Maryland
Brigham and Women's Hospital
Boston, Massachusetts
Southcoast Physicians Group
Fall River, Massachusetts
University of Michigan Hospitals
Ann Arbor, Michigan
Corewell Health
Grand Rapids, Michigan
Mayo Clinic Foundation-Hospital
Rochester, Minnesota
Catholic Medical Center
Manchester, New Hampshire
Valley Hospital
Paramus, New Jersey
Northwell Health
Bay Shore, New York
Kaleida Health
Buffalo, New York
Weill Cornell Medical University
New York, New York
Good Samaritan - Suffern
Suffern, New York
Wake Forest University School of Medicine
Winston-Salem, North Carolina
Bethesda North Hospital
Cincinnati, Ohio
Cleveland Clinic
Cleveland, Ohio
OhioHealth Research and Innovation Institute - Riverside Methodist Hospital
Columbus, Ohio
Oklahoma Heart Institute
Tulsa, Oklahoma
York Hospital
York, Pennsylvania
Vanderbilt University Medical Center
Nashville, Tennessee
University of Texas Medical Branch
Galveston, Texas
Orion Medical
Houston, Texas
Christus Trinity Mother Frances Health System
Tyler, Texas
Intermountain Medical Center
Murray, Utah
Showing 40 of 61 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.